Real-world effectiveness of erythropoiesis-stimulating agents after luspatercept in patients with myelodysplastic syndromes: a retrospective analysis of a large healthcare claims database in the United States
07:30am - 03:35pm EST - April 6, 2024
07:30am - 03:35pm EST - April 6, 2024
Abstract: JNCCN23-0560 https://jnccn.org/view/journal...
Author(s):
- Kashyap Patel, MD, Minnesota Oncology
- Derek Tang, PhD, MS, BSPharm, Health Outcomes Research Leader, Bristol-Myers Squibb
Tags: Outcomes and Health Services Research
| Display Label | Action |
|---|---|
| High Resolution Poster_Hanna _NCCN 2024_ ESA post-lusp.pdf | Download Handout |
| AC24P165 - Real-world effectiveness of erythropoiesis-stimulating agents after luspatercept in patients with myelodysplastic syndromes: a retrospective analysis of a large healthcare claims database in the United States | Download MP3 |